These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37629053)

  • 1. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
    Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.
    Sotirchos ES; Gonzalez Caldito N; Filippatou A; Fitzgerald KC; Murphy OC; Lambe J; Nguyen J; Button J; Ogbuokiri E; Crainiceanu CM; Prince JL; Calabresi PA; Saidha S;
    Ann Neurol; 2020 Jun; 87(6):885-896. PubMed ID: 32285484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.
    Miscioscia A; Puthenparampil M; Miante S; Pengo M; Rinaldi F; Perini P; Gallo P
    J Neurol; 2022 Oct; 269(10):5436-5442. PubMed ID: 35648233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.
    Krämer J; Balloff C; Weise M; Koska V; Uthmeier Y; Esderts I; Nguyen-Minh M; Zimmerhof M; Hartmann A; Dietrich M; Ingwersen J; Lee JI; Havla J; Kümpfel T; Kerschensteiner M; Häußler V; Heesen C; Stellmann JP; Zimmermann HG; Oertel FC; Ringelstein M; Brandt AU; Paul F; Aktas O; Hartung HP; Wiendl H; Meuth SG; Albrecht P
    Nat Commun; 2024 Jun; 15(1):5243. PubMed ID: 38897994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
    PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.
    Ehrhardt H; Lambe J; Moussa H; Vasileiou ES; Kalaitzidis G; Murphy OC; Filippatou AG; Pellegrini N; Douglas M; Davis S; Nagy N; Quiroga A; Hu C; Zambriczki Lee A; Duval A; Fitzgerald KC; Prince JL; Calabresi PA; Sotirchos ES; Bermel R; Saidha S
    Neurology; 2023 Sep; 101(10):e1014-e1024. PubMed ID: 37460235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness
    Lin TY; Motamedi S; Asseyer S; Chien C; Saidha S; Calabresi PA; Fitzgerald KC; Samadzadeh S; Villoslada P; Llufriu S; Green AJ; Preiningerova JL; Petzold A; Leocani L; Garcia-Martin E; Oreja-Guevara C; Outteryck O; Vermersch P; Balcer LJ; Kenney R; Albrecht P; Aktas O; Costello F; Frederiksen J; Uccelli A; Cellerino M; Frohman EM; Frohman TC; Bellmann-Strobl J; Schmitz-Hübsch T; Ruprecht K; Brandt AU; Zimmermann HG; Paul F
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200269. PubMed ID: 38941572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis.
    Glasner P; Sabisz A; Chylińska M; Komendziński J; Wyszomirski A; Karaszewski B
    Restor Neurol Neurosci; 2022; 40(1):35-42. PubMed ID: 35180139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysis.
    Mirmosayyeb O; Yazdan Panah M; Mokary Y; Ghaffary EM; Ghoshouni H; Zivadinov R; Weinstock-Guttman B; Jakimovski D
    J Neurol Sci; 2023 Nov; 454():120847. PubMed ID: 37924591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis.
    El Ayoubi NK; Sabbagh HM; Bou Rjeily N; Hannoun S; Khoury SJ
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36229190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study.
    Paul F; Calabresi PA; Barkhof F; Green AJ; Kardon R; Sastre-Garriga J; Schippling S; Vermersch P; Saidha S; Gerendas BS; Schmidt-Erfurth U; Agoropoulou C; Zhang Y; Seifer G; Petzold A
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2235-2251. PubMed ID: 34792863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study.
    Toscano S; Chisari CG; Biondi A; Patti F
    Neurol Sci; 2024 Nov; 45(11):5385-5394. PubMed ID: 38951431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
    Berek K; Hegen H; Hocher J; Auer M; Di Pauli F; Krajnc N; Angermann R; Barket R; Zinganell A; Riedl K; Deisenhammer F; Berger T; Bsteh G
    Mult Scler; 2022 Oct; 28(12):1871-1880. PubMed ID: 35652366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroid plexus volume as a marker of retinal atrophy in relapsing remitting multiple sclerosis.
    Raghib MF; Bao F; Elkhooly M; Bernitsas E
    J Neurol Sci; 2024 Feb; 457():122884. PubMed ID: 38237367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Optical Coherence Tomography Markers for Multiple Sclerosis Diagnosis and Management.
    Cujba L; Stan C; Samoila O; Drugan T; Benedec Cutas A; Nicula C
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
    Saidha S; Sotirchos ES; Ibrahim MA; Crainiceanu CM; Gelfand JM; Sepah YJ; Ratchford JN; Oh J; Seigo MA; Newsome SD; Balcer LJ; Frohman EM; Green AJ; Nguyen QD; Calabresi PA
    Lancet Neurol; 2012 Nov; 11(11):963-72. PubMed ID: 23041237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis.
    Esmael A; Elsherif M; Abdelsalam M; Sabry D; Mamdouh M; Belal T
    Neurol Res; 2020 Jul; 42(7):564-574. PubMed ID: 32370626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
    Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.